MiR-134 was characterized to regulate resistance to Dox in human breast cancer cells via down-regulation of ABCC1 [22], while miR-132 and miR-212 were identified by Xie et al. to mediated Dox resistance through suppression of PTEN-AKT/NF-κB pathway [23]. Here, AKT1 is linked to breast carcinoma.